These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2335498)

  • 21. The present status of akathisia.
    Sachdev P; Longragan C
    J Nerv Ment Dis; 1991 Jul; 179(7):381-91. PubMed ID: 1869866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron for chronic and persistent akathisia?
    Chengappa KN; Baker RW; Baird J
    J Clin Psychiatry; 1993 Aug; 54(8):320-1. PubMed ID: 7902835
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akathisia causing suicide attempts in patients taking fluoxetine (Prozac).
    Tueth MJ
    J Emerg Med; 1993; 11(3):336-7. PubMed ID: 8340595
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression.
    Amsterdam JD; Hornig-Rohan M; Maislin G
    J Clin Psychiatry; 1994 Sep; 55(9):394-400. PubMed ID: 7929020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Trimetazidine-a new aetiology for extrapyramidal disorders: A case of parkinsonism and akathisia].
    Masmoudi K; Gras-Champel V; Douadi Y; Masson H; Andréjak M
    Therapie; 2005; 60(6):603-5. PubMed ID: 16555505
    [No Abstract]   [Full Text] [Related]  

  • 27. Restless legs syndrome probably induced by risperidone treatment.
    Wetter TC; Brunner J; Bronisch T
    Pharmacopsychiatry; 2002 May; 35(3):109-11. PubMed ID: 12107855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The side effect profile and safety of fluoxetine.
    Wernicke JF
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):59-67. PubMed ID: 3156126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine, akathisia, and suicidality: is there a causal connection?
    Wirshing WC; Van Putten T; Rosenberg J; Marder S; Ames D; Hicks-Gray T
    Arch Gen Psychiatry; 1992 Jul; 49(7):580-1. PubMed ID: 1627050
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periodic limb movement disorder in neuroleptic-induced akathisia.
    Nishimatsu O; Horiguchi J; Inami Y; Sukegawa T; Sasaki A
    Kobe J Med Sci; 1997 Oct; 43(5):169-77. PubMed ID: 9642972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restless legs syndrome.
    McQuillan R; Singh R
    Palliat Med; 1995 Apr; 9(2):168-9. PubMed ID: 7606333
    [No Abstract]   [Full Text] [Related]  

  • 33. Gender differences in the association between antidepressant use and restless legs syndrome.
    Baughman KR; Bourguet CC; Ober SK
    Mov Disord; 2009 May; 24(7):1054-9. PubMed ID: 19353713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic-associated tardive syndromes.
    Jeste DV; Wisniewski AA; Wyatt RJ
    Psychiatr Clin North Am; 1986 Mar; 9(1):183-92. PubMed ID: 2870479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Akathisia and an unusual symptomatic treatment: a case report.
    Back I; Taubert M
    Palliat Med; 2007 Dec; 21(8):713-5. PubMed ID: 18073258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome.
    Horiguchi J; Yamashita H; Mizuno S; Kuramoto Y; Kagaya A; Yamawaki S; Inami Y
    Int Clin Psychopharmacol; 1999 Jan; 14(1):33-6. PubMed ID: 10221640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal akathisia: case reports and a proposed classification of chronic akathisia.
    Lang AE
    Mov Disord; 1994 Mar; 9(2):188-92. PubMed ID: 8196681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.